An alpha-2 agonist suppresses the hyperventilation observed during mild hypercapnia in the setting of spontaneous breathing in healthy volunteers100 and also under spontaneous breathing and cooperative sedation in ARDS patients. This evidence concerns the gene PSMA2 and acute respiratory distress syndrome.